ELI LILLY & Co
Insider Reports History
- Location
- Indianapolis, IN
- Signature
- /s/ Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by ELI LILLY & Co:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aktis Oncology, Inc. | 10%+ Owner | Common Stock | 6,344,114 | $135,446,834 | $21.35 | 12 Jan 2026 | Direct |
| Sigilon Therapeutics, Inc. | 10%+ Owner | Common Stock | 100 | 11 Aug 2023 | Direct |
Insider Reports Filed by ELI LILLY & Co
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 12 Jan 2026 | 0 | $0 | 3 | 10%+ Owner | 15 Jan 2026, 06:01 |
| /report/000089924323018115-eli-lilly-co-2023-08-11 | Sigilon Therapeutics, Inc. | 11 Aug 2023 | 1 | +$25,639,916 | 4 | 10%+ Owner | 14 Aug 2023, 16:30 |
| /report/000089924323017270-eli-lilly-co-2023-06-28 | Sigilon Therapeutics, Inc. | 28 Jun 2023 | 0 | $0 | 3 | 10%+ Owner | 07 Jul 2023, 16:30 |